SU272482A1 - MEDICINE - Google Patents
MEDICINEInfo
- Publication number
- SU272482A1 SU272482A1 SU1235685A SU1235685A SU272482A1 SU 272482 A1 SU272482 A1 SU 272482A1 SU 1235685 A SU1235685 A SU 1235685A SU 1235685 A SU1235685 A SU 1235685A SU 272482 A1 SU272482 A1 SU 272482A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- ulcer
- drug
- enveloping
- pectin
- quercetin
- Prior art date
Links
- 239000003814 drug Substances 0.000 claims description 9
- 229940079593 drugs Drugs 0.000 claims description 7
- 208000000718 Duodenal Ulcer Diseases 0.000 claims description 4
- 210000001736 Capillaries Anatomy 0.000 claims description 3
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims description 3
- 229960001285 Quercetin Drugs 0.000 claims description 3
- 208000007107 Stomach Ulcer Diseases 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- 230000002921 anti-spasmodic Effects 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 201000005917 gastric ulcer Diseases 0.000 claims description 3
- 239000001814 pectin Substances 0.000 claims description 3
- 235000010987 pectin Nutrition 0.000 claims description 3
- 229920001277 pectin Polymers 0.000 claims description 3
- 229930002344 quercetin Natural products 0.000 claims description 3
- 235000005875 quercetin Nutrition 0.000 claims description 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 3
- 238000005728 strengthening Methods 0.000 claims description 3
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 2
- 239000000812 cholinergic antagonist Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 206010068760 Ulcers Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000008032 Gastrointestinal Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000001458 anti-acid Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002757 inflammatory Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening Effects 0.000 description 1
Description
Изобретение относитс к области медицины, а именно к лекарственным препаратам, используемым дл лечени больных звенной болезнью желудка и двенадцатиперстной кишки с повышенной кислотностью.The invention relates to the field of medicine, namely to drugs used for the treatment of patients with gastric ulcer and duodenal ulcer with high acidity.
Известны лекарственные средства дл лечени звенной болезни желудка и двенадцатиперстной кишки с повышенной кислотностью на основе обволакивающих, капилл роукрепл ющих , спазмолитических и противовоспалительных веществ и наполнителей, например викалин, викаир и др. Однако эти препараты часто оказывают побочное действие па организм , в частности раздражают кишечник, что ограничивает их применение при склонности больных к желудочно-кишечным кровотечени м или при наличии у них воспалительных влений в кишечнике или печени.Drugs for treating gastric ulcer and duodenal ulcer with increased acidity are known on the basis of enveloping, capillary strengthening, antispasmodic and anti-inflammatory substances and excipients, such as vikalin, vikair, etc. that limits their use when patients are prone to gastrointestinal bleeding or if they have inflammatory intestinal or liver inflammation.
Целью изобретени вл етс устранение иобочных действий на организм.The aim of the invention is to eliminate the adverse effects on the body.
Дл этого примен ют лекарственное средство , которое содержит натрийкарбоксиметилцеллюлозу , пектин, кверцетин и ликуразид.For this, a drug is used which contains sodium carboxymethyl cellulose, pectin, quercetin and licurazide.
Лекарственное средство готов т в виде гранул , содержащих в 1 вес. ч. по 0,1 вес. ч. натрийкарбоксиметилцеллюлозы и пектина, оказывающих антацидное, обволакивающее и слегка послабл ющее действие, по 0,02 вес. ч. кверцетина и ликуразнда, обладающих капилл роукрепл ющим , противовоспалительным иThe drug is prepared in the form of granules containing 1 wt. h. 0.1 weight. including sodium carboxymethylcellulose and pectin, which provide antacid, enveloping and slightly weakening effect, by 0.02 weight. including quercetin and likuraznda with capillary strengthening, anti-inflammatory and
спазмолитическим действием, и 0,76 вес. ч. наполнителей .antispasmodic effect, and 0.76 wt. including fillers.
Лекарственное средство назначают больным звенной болезнью желудка и двенадцатиперстной кишки с повышенной кислотностью по половине или одной чайной ложке 3 раза в день перед едой. Одновременно с препаратом больной принимает 0,5 стакана теплой воды. Курс лечени 3-4 недели.The drug is prescribed to patients with ulcer ulcer and duodenal ulcer with high acidity in half or one teaspoon 3 times a day before meals. Simultaneously with the drug, the patient takes 0.5 cups of warm water. The course of treatment is 3-4 weeks.
Предмет изобретени Subject invention
Claims (2)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU272482A1 true SU272482A1 (en) |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007250624B2 (en) | A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides | |
| US10758561B2 (en) | Composition based on xyloglucan and proteins for the treatment of intestinal disorders | |
| SU272482A1 (en) | MEDICINE | |
| WO1982000762A1 (en) | Agent for alimentary canal | |
| KR101488921B1 (en) | Mint liquid for improving digestive functions and manufacturing method thereof | |
| Drach et al. | Toxicity of the Common Houseplant Dieffenbachia: Report of a Case | |
| Reddy et al. | Sucralfate therapy for lye-induced esophagitis. | |
| CN110339272B (en) | Traditional Chinese medicine composition for treating coronary heart disease and peptic ulcer after PCI (percutaneous coronary intervention) operation and preparation method thereof | |
| KR20190044734A (en) | Composition for treating high blood pressure | |
| RU2676085C1 (en) | Method of obtaining plant-based medicine of anti-inflammatory and antimicrobial action | |
| KR20040097871A (en) | A herb extract that has prevention and cure effects on gastritis and peptic ulcer | |
| RU2283662C2 (en) | Gastroenterological preparation | |
| RU2039566C1 (en) | Method for treating inflammatory and dystrophic diseases of mucous membranes of digestive organs | |
| RU2160104C2 (en) | Method and medicinal preparation for treating peptic ulcers | |
| US20130071473A1 (en) | Composition and method for treating ulcers | |
| CN111588751A (en) | A Chinese medicinal composition for treating acute gastroenteritis and dysentery | |
| CN1184982C (en) | Ulcer treating capsule and its prepn | |
| Porro et al. | A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse | |
| US8323702B2 (en) | Composition and method for treating ulcers | |
| WO2023026231A1 (en) | Composition for the prevention and/or treatment of gastric and esophageal diseases | |
| IT202100021995A1 (en) | Composition for the prevention and/or treatment of gastric and oesophageal pathologies | |
| CN105687937A (en) | Nursing medicine ointment for treating burns and scalds and preparing method of nursing medicine ointment | |
| CN106822710A (en) | It is a kind of to treat Chinese medicine composition and preparation method that blood-head holds the stasis of blood and excessive noxious heat card under the arm | |
| WO2014171201A1 (en) | Oral phosphorus-adsorbing agent of low calcium absorption type | |
| UA109851C2 (en) | PHARMACEUTICAL COMPOSITION based on beekeeping products for local treatment of gastric ulcer and duodenum |